Kathryn Jean Boor Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Kathryn Jean Boor is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 8,263 shares of SRPT, which is worth approximately $181,538. The most recent transaction as insider was on Mar 10, 2025, when has been sold 2,383 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.26K

0% 3M change

9.94% 12M change

Total Value Held $181,538

Kathryn Jean Boor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2025	BUY Grant, award, or other acquisition	-	2,383 Added 22.38%	8,263 Common Stock
Dec 05 2024	SELL Open market or private sale	$205,399 $125.55 p/Share	1,636 Reduced 21.77%	5,880 Common Stock
Mar 11 2024	SELL Open market or private sale	$93,549 $122.93 p/Share	761 Reduced 9.19%	7,516 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	1,846 Added 18.24%	8,277 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	1,523 Added 19.15%	6,431 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	4,908 Added 50.0%	4,908 Common Stock

Also insider at

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials

Director

KJB